GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: HTWR
Neutral

HEARTWARE (NASDAQ: HTWR) rated to Neutral by JP Morgan

Tuesday,  Jan 12, 2016  10:25 AM ET by Kristen Bailey

JP Morgan
rated HEARTWARE (NASDAQ: HTWR) to Neutral.

HeartWare International, Inc. (HeartWare), formerly HeartWare Limited, along with its subsidiaries, is a medical device company focused on developing small implantable pumps for the treatment of advanced heart failure. The Company?s product, the HeartWare Ventricular Assist System (the HeartWare System), includes a left ventricular assist device (LVAD), related accessories and surgical tools and is designed to provide circulatory support for patients with advanced heart failure. The core of the HeartWare System is a continuous flow blood pump, ventricular assist device (the HVAD Pump), a full-output device capable of pumping up to 10 liters of blood per minute. In January 2009, the HeartWare System received Conformite Europeene (CE) Marking, which allows for commercial sales in Europe and is the subject of an ongoing United States bridge-to-transplant clinical trial under an investigational device exemption (IDE) granted by the Food and Drug Administration of United States (FDA).

JPMorgan is a leading financial services firm with one of the largest client franchises in the world. We partner with our clients to offer the most complete and innovative solutions in the industry to help them achieve their goals. For more than 200 years, we have taken a long-term approach to our clients and to the way we conduct business. Our firm has grown considerably in scale and scope, but our commitment to our core principle of doing "only first-class business... in a first-class way" has never been stronger.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy